Navigation Links
Abbott Highlights Strong Corporate Responsibility Performance With Release of 2008 Global Citizenship Report
Date:4/27/2009

Company's Report Outlines Strategic Citizenship Priorities: Innovating for the Future, Enhancing Access, Safeguarding the Environment and Protecting Patients and Consumers

ABBOTT PARK, Ill., April 27 /PRNewswire/ -- Abbott today announced the release of its 2008 Global Citizenship Report entitled, "Advancing Innovation." The report provides an update on Abbott's progress and results in 2008 in delivering on the company's mission to improve people's lives around the world, focused on four key areas: innovating for the future, enhancing access, safeguarding the environment, and protecting patients and consumers.

"We appreciate this opportunity to share news of our continued progress in addressing the most important impacts that our company makes in our world," said Miles D. White, chairman and chief executive officer, Abbott. "These are the areas in which our business has the greatest effects on society and the environment, and which offer us the greatest opportunity to make a difference in the challenges facing our world today."

Key highlights of Abbott's citizenship work in 2008 include:

  • Innovating for the Future - Abbott invested $2.7 billion in research and development, helping its more than 7,000 scientists to bring forward nine significant new product approvals across all of its businesses, including medical products, nutritionals and pharmaceuticals.
  • Enhancing Access - As part of its core business strategy and in partnership with others, Abbott made significant progress in helping people around the world to gain access to medicine and health care. A few examples of this work: Abbott provided more than 155,000 patients with free
    '/>"/>

SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Abbott to Present at Bear Stearns Healthcare Conference
2. The National Center for Missing & Exploited Children, Wal-Mart, and Abbott Host Child Safety Events
3. Dow Jones Sustainability Index Again Recognizes Abbott for Continued Leadership in Business, Environmental and Social Performance
4. Abbott Declares 335th Consecutive Quarterly Dividend
5. Abbott Again Honored as Top Company for Working Moms
6. Abbotts HUMIRA(R) (adalimumab) Honored With Prestigious Galen Prize for Innovation in Patient Care
7. Abbott Hosts Conference Call for Third-Quarter Earnings
8. Abbott Broadens Use of i-STAT Handheld Blood Analyzer with CLIA Waiver Granted by FDA for CHEM8+ Test Cartridge
9. Abbott Named One of the Best Companies for Hispanics by Hispanic Business Magazine
10. Abbott Again Honored as a Leader in Diversity
11. Abbott Researchers Target Neuronal Nicotinic Receptors for Treatment of Pain and Cognition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ... pivotal Phase 2b 003-A1 study, known as the ... heavily pre-treated relapsed and refractory multiple myeloma patients. ... Joint Symposium at the 51st annual meeting of ... Orleans. Enrollment in this trial is complete (n=269), ...
(Date:12/6/2009)... clotting, or coagulation, is an important process that ... injured. Sometimes, however, clots form on the inside ... not dissolve naturally, a potentially life-threatening situation requiring ... Meeting of the American Society of Hematology reveals ... and heparin with the hope of preventing clots ...
(Date:12/6/2009)... Disorders information and Treatment site www.sleeping-with-a-sleeping-disorder.com ... with herbal or natural sleep aids from around ... for a good cause. The submissions will be ... Aids ,Encyclopedia, by YOU, to be sold from ... will donate 100% of the proceeds ,from sales ...
(Date:12/6/2009)... Fox, LLP says dangerous substances such as asbestos have been found ... ... York, NY (PRWEB) December 6, 2009 -- As parents shop for ... reports of recalls due to lead paint or asbestos contamination, says ... visit hospital emergency rooms each year due to toy-related injuries,” says ...
(Date:12/5/2009)... ORLEANS, Dec. 5 There have been significant scientific ... experts continue to gain a better understanding of how ... options and provide patients with the best care. Research ... American Society of Hematology explores optimal induction therapies for ...
Breaking Medicine News(10 mins):Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 3Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 4Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 5Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 3Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 4Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 5Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 6Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 7Health News:Donate a Herbal Natural Sleep Aid to the Internet's First "Natural Sleep Aids E-book" Written by People Just Like You 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8
... For statues, stress injuries come from standing in place for ... developed a way to predict such fracturing, applying the procedure ... and more accurate than previous methods. , In applying ... the researchers are also gaining new perspective on how these ...
... million patients treated at nearly 2,000 hospitals nationwide ... ... Ind., March 18 Press Ganey Associates,Inc., the health care industry,s ... Patient Perspectives on,American Health Care. The report examines patient satisfaction across ...
... Wash., March 18 As the April 15 ... allowed for long term care,insurance, according to LTC ... care insurance agency., *(PHOTO 72dpi: Send2Press.com/mediaboom/07-0807-LTCTruesdell_72dpi.jpg), ... "People with LTC policies can deduct substantial sums," ...
... NutraCea (OTC Bulletin,Board: NTRZ), a world leader in stabilized ... Crow will step down from,his role as Chief Financial Officer ... assume the role of Chief Financial Officer on that date.,Mr. ... ensure a smooth,transition of his responsibilities to Mr. Mueller., ...
... Visits, From Child Life Specialists at The Children,s ... March 16th - 23rd, PHILADELPHIA, March 17 ... involve fear and tears. At least that,s the,goal of ... Philadelphia.,This team, consisting of Certified Child Life Specialists and ...
... centre on Innovation and Technology (UNU-MERIT) and the United ... a forum on monetary prizes as an alternative to ... development. , The objective of the forum Prize or ... be used to direct pharmacuetical research to more socially ...
Other Medicine News:Health News:Tell them where it hurts 2Health News:Tell them where it hurts 3Health News:National Report on Patient Perspectives of Hospital Care Released Today 2Health News:TAX ALERT: Deductions for Long Term Care Insurance Premiums 2Health News:NutraCea Appoints New Chief Financial Officer 2Health News:NutraCea Appoints New Chief Financial Officer 3Health News:A Child's Trip to the Hospital Doesn't Always Have to Involve Fear and Tears 2Health News:A Child's Trip to the Hospital Doesn't Always Have to Involve Fear and Tears 3
(Date:12/4/2009)... Northwest Biotherapeutics, Inc. ("NWBT" or the "Company") (OTC Bulletin ... Trademark Office has allowed its patent application on a ... manufacture of the Company,s DCVax® therapeutic cancer vaccines. ... high concentration of dendritic cells (which are the critical ...
(Date:12/3/2009)... Pa., Dec. 3 Ambry Genetics and SoftGenetics ... provide extended bioinformatics genomics services using SoftGenetics, NextGENe ... ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20090428/LA06744LOGO ) ... team at Ambry has been providing genomics solutions ...
(Date:12/3/2009)... Radiology imaging leader MEDRAD, Inc. demonstrated PACS* injection-record ... of North America in Chicago. The ... capabilities of its kind, is the latest release ... Platform . ,, (Photo: ...
Breaking Medicine Technology:Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3GenVec Announces Second Quarter 2009 Results Conference Call 53211 1GenVec Announces Second Quarter 2009 Results Conference Call 53211 2Suicide Genes Help Slow Ovarian Tumor Growth in Mice 53210 1Suicide Genes Help Slow Ovarian Tumor Growth in Mice 53210 2CSCs FirstDoc Recognized by EMC as a Preferred Regulatory Compliance Application for Life Sciences Industry 53205 1CSCs FirstDoc Recognized by EMC as a Preferred Regulatory Compliance Application for Life Sciences Industry 53205 2CSCs FirstDoc Recognized by EMC as a Preferred Regulatory Compliance Application for Life Sciences Industry 53205 3
The full body blanket provides coverage to the entire patient....
The upper body blanket is typically used for abdominal or lower body procedures. The upper body blankets warms the upper torso and arms. A clear drape is included to cover and warm the intubated pati...
This product is for the lower body and uses a Convective Warming System which is both soft and comfortable. Constructed of 2-ply material consisting of polyethylene film inner layer and non-woven out...
Cocoon Disposable Patient Warming Blankets are specially designed to prevent hypothermia and maintain normothermia in your patients. The soft warm coloured material is strong and resists tearing and ...
Medicine Products: